Hai Jiang

Title: Hai Jiang - Innovator in Biomedicine

Introduction

Hai Jiang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biomedicine, particularly in the development of pharmaceutical compositions for treating various types of cancer. With a total of 3 patents, his work is recognized for its potential impact on cancer treatment.

Latest Patents

One of Hai Jiang's latest patents is a combined pharmaceutical composition for treating tumors. This application focuses on a composition that includes an anti-PD-L1 antibody and anlotinib, demonstrating effective activity against biliary tract tumors, liver cancer, triple-negative breast cancer, and lung cancer. Another notable patent is for a quinoline derivative specifically designed for the treatment of triple-negative breast cancer. This invention outlines the use of a particular quinoline derivative in preparing a pharmaceutical composition aimed at combating this aggressive form of cancer.

Career Highlights

Throughout his career, Hai Jiang has worked with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he has contributed to various innovative projects in the pharmaceutical industry. His expertise in biomedicine has positioned him as a key figure in the development of new cancer therapies.

Collaborations

Hai Jiang has collaborated with notable colleagues, including Xunqiang Wang and Xiquan Zhang. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Hai Jiang's contributions to biomedicine, particularly in cancer treatment, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.